Clinical Chemistry · 2004 · 327 citations · 30 references
MedicineMolecular BiologyOncologyCarcinogenesisGene ExpressionMolecular OncologyCancer BiomarkersCancer TranscriptomicsComparative Cancer Gene Expression ProfilesDifferential Gene ExpressionDifferential Transcript ExpressionFluorescent ProbesHepatocellular Carcinoma PathogenesisTissue Expression Profiles
BACKGROUND: Eph receptors and their ligands, the ephrins, represent a large class of cell-cell communication molecules with well-defined developmental functions. Their role in healthy adult tissues and in human disease is still largely unknown, although diverse roles in carcinogenesis have been postulated. METHODS: We established a set of fluorescent PCR probes and primers for the definition of individual gene expression profiles of 12 different Eph receptors and 8 ephrins in 13 different healthy tissues. The mRNA expression profiles were studied in human lung, colorectal, kidney, liver, and brain cancers. RESULTS: The family of Eph receptors/ephrins was widely expressed in adult tissues with organ-site-specific patterns: EphB6 was highest in the thymus, compatible with an involvement in T-cell maturation. Brain and testis shared a unique pattern with EphA6, EphA8, and EphB1 being the most prominent. EphA7 had a high abundance in the kidney vasculature. Ephrin-A3 was up-regulated 26-fold in lung cancer, and EphB2 was up-regulated 9-fold in hepatocellular carcinoma. EphA8 was down-regulated in colon cancer, and EphA1/EphA8 was down-regulated in glioblastomas. CONCLUSION: Eph/Ephrin genes are widely expressed in all adult organs with certain organ-site-specific patterns. Because their function in adult tissues remains unknown, further analysis of their role in disease may disclose new insights beyond their well-defined meaning in development.
30
Crystal structure of an Eph receptor–ephrin complex
Juha‐Pekka Himanen, Kanagalaghatta R. Rajashankar, Martin Lackmann et al. · Nature · 2001 · 336 citations
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Dana M. Brantley, Nikki Cheng, Erin J Thompson et al. · Oncogene · 2002 · 317 citations
Medicine, Cancer Biology, Oncology +10
Overexpression of the EphA2 tyrosine kinase in prostate cancer
Jennifer Walker‐Daniels, Karen Coffman, M. Azimi et al. · The Prostate · 1999 · 271 citations